Executive Employment AgreementExecutive Employment Agreement • March 20th, 2025 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 20th, 2025 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of March 19, 2025 (“Effective Date”), by and between Dr. David Young (the “Executive”) and Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Processa”) (collectively referred to herein as the “Parties”).
Executive Employment AgreementExecutive Employment Agreement • March 20th, 2025 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 20th, 2025 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of March 19, 2025 (“Effective Date”), by and between Dr. Sian Bigora (the “Executive”) and Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Processa”) (collectively referred to herein as the “Parties”).
Executive Employment AgreementExecutive Employment Agreement • March 20th, 2025 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 20th, 2025 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of March 19, 2025 (“Effective Date”), by and between George Ng (the “Executive”) and Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Processa”) (collectively referred to herein as the “Parties”).
Executive Employment AgreementExecutive Employment Agreement • March 20th, 2025 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 20th, 2025 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of March 19, 2025 (“Effective Date”), by and between Wendy Guy (the “Executive”) and Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Processa”) (collectively referred to herein as the “Parties”).
Executive Employment AgreementExecutive Employment Agreement • March 20th, 2025 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 20th, 2025 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of March 19, 2025 (“Effective Date”), by and between Russell Skibsted (the “Executive”) and Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Processa”) (collectively referred to herein as the “Parties”).
Executive Employment AgreementExecutive Employment Agreement • March 20th, 2025 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 20th, 2025 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of March 19, 2025 (“Effective Date”), by and between Patrick Lin (the “Executive”) and Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Processa”) (collectively referred to herein as the “Parties”).
Executive Employment AgreementExecutive Employment Agreement • July 17th, 2024 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 17th, 2024 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is made and entered into as of July 15, 2024 (“Effective Date”), by and between Russell Skibsted (the “Executive”) and Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company” or “Processa”) (collectively referred to herein as the “Parties”).